ICON plc is expanding its oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly Health and Care in Illinois.

The new institute strengthens Accellacare’s ability to support oncology clinical trials and broadens access to innovative cancer treatments for patients. The institute includes:

• 14 medical oncologists
• Three radiation oncologists
• Nine fellowship-trained surgical specialists in urologic oncology, breast surgery, colorectal surgery, endocrine surgery, and general surgical oncology

This development builds on Accellacare’s existing oncology expertise at the McFarland Clinic in Ames, Iowa, and reflects ICON’s commitment to addressing patient recruitment for oncology trials, which is one of the most pressing challenges in clinical development.

Brian Mallon EVP, Sites & Patient Solutions, ICON, said, “Our partnership with the Brian Moran Cancer Institute marks a major step forward in our mission to accelerate oncology research and improve patient access to new therapies. Through our collaboration, we are expanding our investigator base and developing a flagship oncology site, creating more opportunities for sponsors and patients alike. Together we’re working to bring hope to people affected by cancer.”